HemaSphere
(Jun 2022)
Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force
- Isabel Dombrink,
- Bart R. Lubbers,
- Loredana Simulescu,
- Robin Doeswijk,
- Olga Tkachenko,
- Elisabeth Dequeker,
- Alan G. Fraser,
- Jacques J. M. van Dongen,
- Christa Cobbaert,
- Monika Brüggemann,
- Elizabeth Macintyre
Affiliations
- Isabel Dombrink
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- Bart R. Lubbers
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- Loredana Simulescu
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- Robin Doeswijk
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- Olga Tkachenko
- 6 DG for Health and Food Safety, European Commission, Brussels, Belgium
- Elisabeth Dequeker
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- Alan G. Fraser
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- Jacques J. M. van Dongen
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- Christa Cobbaert
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- Monika Brüggemann
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- Elizabeth Macintyre
- 1 BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium
- DOI
-
https://doi.org/10.1097/HS9.0000000000000724
- Journal volume & issue
-
Vol. 6,
no. 6
p.
e724
WeChat QR code